Free and total plasma tryptophan in endogenous depression

Area of Science:

• Biochemistry
• Neuroscience
• Psychiatry

Background:

• Tryptophan is a precursor to serotonin, a neurotransmitter implicated in mood regulation.
• Altered tryptophan levels have been hypothesized to play a role in depression.
• Investigating plasma tryptophan concentrations may offer insights into depression pathophysiology and treatment response.

Purpose of the Study:

• To measure free and total plasma tryptophan concentrations in female depressive patients.
• To determine if these concentrations differ between unipolar and bipolar depression.
• To assess the predictive value of tryptophan levels for L-tryptophan treatment outcomes.

Main Methods:

• Plasma samples were collected from 41 female patients diagnosed with depression.
• Free and total plasma tryptophan concentrations were quantified.
• Fifteen patients received L-tryptophan treatment, and treatment response was evaluated.

Main Results:

• Basal free and total plasma tryptophan levels were found to be normal in drug-free depressed patients and those on lithium.
• No significant differences in tryptophan concentrations were observed between unipolar and bipolar depressed subjects.
• Plasma tryptophan levels did not predict recovery from depression following L-tryptophan therapy.

Conclusions:

• The study suggests that basal free plasma tryptophan concentration is normal in depressed subjects.
• Neither free nor total plasma tryptophan concentrations appear to be reliable predictors for the efficacy of L-tryptophan treatment in depression.
• Further research may be needed to explore other biomarkers or treatment strategies for depression.